$140 Million is the total value of Newman Dignan & Sheerar, Inc.'s 147 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | S&P 500 Spdretf | $798,000 | +0.5% | 3,864 | 0.0% | 0.57% | +20.0% | |
| CSCO | Cisco Systems | $709,000 | -1.1% | 25,764 | 0.0% | 0.51% | +17.9% | |
| STT | State Street Boston Corp | $675,000 | -6.2% | 9,175 | 0.0% | 0.48% | +11.8% | |
| COP | Conoco Phillips | $549,000 | -9.7% | 8,811 | 0.0% | 0.39% | +7.7% | |
| IVE | iShares S&P 500 Barra Value Fdetf | $500,000 | -1.2% | 5,400 | 0.0% | 0.36% | +17.8% | |
| D | Dominion Res Inc Va | $485,000 | -8.0% | 6,850 | 0.0% | 0.35% | +9.8% | |
| LQD | iShares Inv. Grade Corp. Bd.etf | $438,000 | +1.9% | 3,600 | 0.0% | 0.31% | +21.8% | |
| NVS | Novartis A G | $382,000 | +6.7% | 3,869 | 0.0% | 0.27% | +27.6% | |
| DOW | Dow Chemical | $377,000 | +5.3% | 7,860 | 0.0% | 0.27% | +25.7% | |
| ROP | Roper Industries Inc | $368,000 | +10.2% | 2,139 | 0.0% | 0.26% | +31.5% | |
| MDY | S&P 400 Mid-Cap SPDRetf | $358,000 | +5.0% | 1,290 | 0.0% | 0.26% | +25.5% | |
| CCF | Chase Corp | $350,000 | +21.5% | 8,000 | 0.0% | 0.25% | +45.3% | |
| PPG | PPG Inds Inc | $324,000 | -2.4% | 1,438 | 0.0% | 0.23% | +16.1% | |
| WBA | Walgreens Boots Allianc | $296,000 | +11.3% | 3,494 | 0.0% | 0.21% | +32.7% | |
| LMT | Lockheed Martin Corp | $287,000 | +5.5% | 1,413 | 0.0% | 0.20% | +25.8% | |
| IBM | International Business Machine | $285,000 | 0.0% | 1,777 | 0.0% | 0.20% | +19.4% | |
| ESRX | Express Scripts Inc | $262,000 | +2.3% | 3,019 | 0.0% | 0.19% | +22.2% | |
| AON | AON Corp | $242,000 | +1.3% | 2,517 | 0.0% | 0.17% | +21.0% | |
| RDSA | Royal Dutch Shell PLC | $212,000 | -10.9% | 3,551 | 0.0% | 0.15% | +6.3% | |
| TEAR | Tearlab Corp | $20,000 | -25.9% | 10,000 | 0.0% | 0.01% | -12.5% | |
| LIQDQ | Liquid Hldgs Group Inc | $3,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-04-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Schwab Dow Jones US Div Eq ETF | 42 | Q3 2023 | 6.6% |
| Schwab Dow Jones US Large Cap ETF | 42 | Q3 2023 | 7.3% |
| Schwab Dow Jones US Large Growth ETF | 42 | Q3 2023 | 4.9% |
| Schwab Dow Jones US Large Value ETF | 42 | Q3 2023 | 4.5% |
| Apple, Inc | 42 | Q3 2023 | 20.8% |
| Schwab Dow Jones US Sm-Cap ETF | 42 | Q3 2023 | 13.5% |
| Microsoft Corp | 42 | Q3 2023 | 3.4% |
| Johnson & Johnson | 42 | Q3 2023 | 2.9% |
| Novartis A G | 42 | Q3 2023 | 56.8% |
| Merck & Co Inc | 42 | Q3 2023 | 2.5% |
View Newman Dignan & Sheerar, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-04-28 |
| 13F-HR | 2023-01-20 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-04-14 |
| 13F-HR | 2022-01-18 |
View Newman Dignan & Sheerar, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.